SRPL — Shreeram Proteins Income Statement
0.000.00%
Last trade - 00:00
- IN₹246.33m
- IN₹616.41m
- IN₹1.63bn
- 29
- 69
- 16
- 27
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,581 | 1,559 | 1,526 | 2,878 | 1,627 |
Cost of Revenue | |||||
Gross Profit | 164 | 128 | 111 | 179 | 146 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,505 | 1,493 | 1,478 | 2,758 | 1,532 |
Operating Profit | 76.6 | 65.6 | 47.5 | 120 | 95.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 44.4 | 35.1 | 11 | 82.4 | 52.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.4 | 26.1 | 8.37 | 61.4 | 38.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 33.4 | 26.1 | 8.37 | 61.4 | 38.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33.4 | 26.1 | 8.37 | 61.4 | 38.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.13 | 0.102 | 0.033 | 0.239 | 0.15 |